Published in
Elsevier, Leukemia Research, (69), p. 12-17
DOI: 10.1016/j.leukres.2018.03.015
Links
Tools
Lenalidomide treatment in lower risk myelodysplastic syndromes—The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients)
Journal article published in 2018 by
Anna Jonasova,
Radana Neuwirtova,
Helena Polackova,
Magda Siskova,
Tomas Stopka,
Eduard Cmunt,
Alena Moudra 
,
Lubomir Minarik,
Monika Belickova ,
Ota Fuchs,
Kyra Michalova,
Zuzana Zemanova
,
Lubomir Minarik,
Monika Belickova ,
Ota Fuchs,
Kyra Michalova,
Zuzana Zemanova
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 